BS
Bonstein Sara Director Financiero
Other F
Historial del iniciado Director Financiero Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Browse the complete record of transactions filed by Bonstein Sara, Director Financiero. Director active across 4 companies, notably INSMED Inc. Cumulatively, 34 reports have been logged. Split: 0 buy · 15 sells. Total volume traded: €5.2m. Activity tracked since 11 January 2022. The latest transaction was disclosed on 3 June 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bonstein Sara Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones 34 en total
▼ Chief Financial Officer · Directivos · 3 jun 2026 · INSMED Inc 2404 títulos @ 102,27 US$ 0.0009% mcap 20.0% de su flujo Common Stock SEC:0001604019-26-000010:0
▼ Chief Financial Officer · Directivos · 13 may 2026 · INSMED Inc 8272 títulos @ 116,18 US$ 0.0022% mcap 94.1% de su flujo Common Stock SEC:0001604019-26-000008:0
▼ Chief Financial Officer · Directivos · 3 feb 2026 · INSMED Inc 748 títulos @ 156,34 US$ 8.9% de su flujo Common Stock SEC:0001604019-26-000006:0
▼ Chief Financial Officer · Directivos · 6 ene 2026 · INSMED Inc 1517 títulos @ 173,33 US$ 20.2% de su flujo Common Stock SEC:0001604019-26-000004:0
◆ Chief Financial Officer · Directivos · 2 ene 2026 · INSMED Inc 5998 títulos Common Stock SEC:0001604019-26-000002:0
◇ Chief Financial Officer · Directivos · 21 jul 2025 · INSMED Inc 3443 títulos @ 26,46 US$ 9.9% de su flujo Common Stock SEC:0001628280-25-035755:0
◇ Chief Financial Officer · Directivos · 7 jul 2025 · INSMED Inc 6244 títulos @ 19,74 US$ 6.8% de su flujo Common Stock SEC:0001604019-25-000003:0
◇ Chief Financial Officer · Directivos · 23 jun 2025 · INSMED Inc 35.253 títulos @ 18,95 US$ 39.8% de su flujo Common Stock SEC:0001628280-25-033020:0
◇ Chief Financial Officer · Directivos · 10 jun 2025 · INSMED Inc 24.150 títulos @ 18,95 US$ 56.3% de su flujo Common Stock SEC:0001628280-25-030961:0
▼ Chief Financial Officer · Directivos · 3 jun 2025 · INSMED Inc 1579 títulos @ 71,50 US$ 31.9% de su flujo Common Stock SEC:0001628280-25-029405:0
◆ Chief Financial Officer · Directivos · 15 may 2025 · INSMED Inc 6508 títulos 0Common Stock SEC:0001628280-25-026586:0
▼ Chief Financial Officer · Directivos · 13 may 2025 · INSMED Inc 8870 títulos @ 67,81 US$ 14.2% de su flujo Common Stock SEC:0001628280-25-025980:0
▼ Chief Financial Officer · Directivos · 18 feb 2025 · INSMED Inc 17.622 títulos @ 80,28 US$ 35.5% de su flujo Common Stock SEC:0001628280-25-006804:0
▼ Chief Financial Officer · Directivos · 11 feb 2025 · INSMED Inc 13.302 títulos @ 80,00 US$ 27.2% de su flujo Common Stock SEC:0001628280-25-005465:0
◆ Chief Financial Officer · Directivos · 5 feb 2025 · INSMED Inc 65.033 títulos 0Common Stock SEC:0001628280-25-004459:0
▼ Chief Financial Officer · Directivos · 7 ene 2025 · INSMED Inc 3470 títulos @ 65,70 US$ 5.8% de su flujo Common Stock SEC:0001628280-25-001206:0
◇ Chief Financial Officer · Directivos · 28 may 2024 · INSMED Inc 3454 títulos @ 28,88 US$ 2.4% de su flujo Common Stock SEC:0001628280-24-025886:0
◆ Chief Financial Officer · Directivos · 13 may 2024 · INSMED Inc 14.518 títulos Common Stock SEC:0001628280-24-023591:0
▼ Chief Financial Officer · Directivos · 9 ene 2024 · INSMED Inc 4497 títulos @ 29,18 US$ 3.2% de su flujo Common Stock SEC:0001628280-24-001160:0
◆ Chief Financial Officer · Directivos · 4 ene 2024 · INSMED Inc 12.873 títulos Common Stock SEC:0001628280-24-000691:0
▼ Chief Financial Officer · Directivos · 22 dic 2023 · INSMED Inc 13.199 títulos @ 30,00 US$ 9.5% de su flujo Common Stock SEC:0001628280-23-042628:0
▼ Chief Financial Officer · Directivos · 15 may 2023 · INSMED Inc 2210 títulos @ 19,30 US$ 1.0% de su flujo Common Stock SEC:0001628280-23-018679:0
◆ Chief Financial Officer · Directivos · 11 may 2023 · INSMED Inc 34.300 títulos Common Stock SEC:0001628280-23-018160:0
▼ Chief Financial Officer · Directivos · 10 ene 2023 · INSMED Inc 2857 títulos @ 18,12 US$ 1.3% de su flujo Common Stock SEC:0001628280-23-000958:0
◆ Chief Financial Officer · Directivos · 5 ene 2023 · INSMED Inc 8232 títulos Common Stock SEC:0001628280-23-000632:0
25 de 34 declaraciones
Ver más (9 restantes) About Bonstein Sara Bonstein Sara is Directeur Financier, with Chief Financial Officer roles at INSMED Inc and Advaxis, Inc. She has 34 filings, and across the 34 sampled filings, they cover the period from 2016-01-04 to 2026-06-05, with 0 in buys and 5212168 in sells, and the modal transaction nature is sale.